+212.3%
BMNR vs CVS
+55.6%
+156.7%
-90.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.1% | +0.1% | 0.0% |
| 7D | -8.5% | -2.0% | -6.5% | -7.7% |
| 30D | +33.8% | +1.9% | +31.9% | +32.1% |
| 3M | +54.7% | -2.2% | +56.9% | +54.2% |
| 6M | +16.7% | +26.7% | -10.0% | -4.6% |
| YTD | -10.9% | +22.9% | -33.7% | -30.8% |
| 1Y | -46.9% | +32.9% | -79.8% | -64.7% |
| All | +212.3% | +55.6% | +156.7% | +29.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling